Skip to content
Agentic OS
Menu

Intelligence / Healthtech & medtech market map / Medical devices / Therapeutic and rehabilitation devices

SubmarketREVIEWEDResearched 14 Nov 2026 · refreshed weekly

Therapeutic and rehabilitation devices

Devices that deliver therapy, support mobility or rehabilitation, or administer treatment outside a device-based diagnostic workflow. Includes infusion and drug-delivery pumps, ventilators, dialysis devices, mobility aids, rehabilitation equipment and associated disposables.

Market size
$150B
$150B ($139B–$154B) · 2026 · Bottom-up
Growth
+6.3%
$260B by 2035
Attractiveness
— /100
for B2B sellers
Evidence
Low confidence
2 sources · Bottom-up
Level
Submarket
Segmented by
Use case
Buyers
Hospitals, ambulatory and alternative-care sites, home-care providers, physician practices
Buying centre
Clinical leadership, therapy services, nursing leadership, procurement, value analysis, finance
Maturity
Growth
Structure
Fragmented
Buying triggers
  • New reimbursement for home treatment
  • Expansion of dialysis, infusion and rehabilitation capacity
  • Launches of safer or more portable therapeutic devices
  • Hospital and home-care replacement cycles
Pains
  • Buyers need evidence that devices reduce care burden and total treatment cost
  • Patient adherence and training requirements can undermine device effectiveness
  • Consumable supply, cleaning and infection control affect utilization
  • Compatibility across patient-care settings creates implementation complexity
Scores (1–5)
Pain intensity—
Purchasing power—
Reachability—
Growth—
Growth drivers
  • Hospitals, dialysis providers, infusion services, rehabilitation facilities and home-care organizations buy infusion pumps, ventilators, dialysis devices, mobility aids and associated disposables.
  • Aging populations and chronic disease increase demand for treatment and support devices [6][7].
  • The move of care into the home expands distributed treatment-device purchasing [6].
  • Technological progress enables safer, more portable and more connected equipment [5].
Headwinds
  • Reimbursement constraints affect device and home-treatment adoption [7].
  • Pricing pressure limits provider and vendor margins [7].
  • Tighter regulatory requirements add clinical-evidence and documentation costs [7].
  • Training, cleaning and infection-control requirements create operational burden.
Trends
  • Home infusion and home respiratory support are expanding purchasing beyond hospitals [6].
  • Connected pumps and therapy devices are gaining importance for remote management.
  • Associated disposables generate recurring revenue tied to treatment volume.
  • Rehabilitation demand is broadening beyond inpatient facilities.

Niches 5

Split by customer type.

Niche85/100

Dialysis machines, consumables and home dialysis systems

Dialysis providers, hospitals and home dialysis programmes buying haemodialysis machines, peritoneal dialysis cyclers, dialysers, tubing and related consumables for in-centre and h

—
Dialysis providers and renal care organisations (plus hospital dialysis units)
not sizedOpen
Niche80/100

Hospital infusion and drug-delivery pump programmes

Acute-care hospitals and large ambulatory infusion centres buying infusion pumps, syringe pumps, elastomeric and volumetric pumps plus administration sets and consumables for IV, s

—
Hospitals (acute-care and infusion centres)
not sizedOpen
Niche65/100

Rehabilitation equipment and therapy-device programmes

Hospitals, ambulatory rehabilitation centres, skilled nursing facilities and physician practices buying physical and occupational therapy devices and rehabilitation equipment: ther

—
Ambulatory rehabilitation centres, hospitals, skilled nursing facilities and physician practices
not sizedOpen

Companies in this market 8

Named in public sources; linked to the source.

How this was sized

$150B ($139B–$154B) · 2026 · Bottom-up

No source provides a matching share for this submarket. Bottom-up share assumption: 24% of the scoped sector. Arithmetic: $623.37bn x 24% = $149.609bn in 2026. Low and high estimates apply 24% to the sector range from [4]. Constant-share forecast: $149.609bn x 1.0634^9 = $260.152bn in 2035.

Alongside it in Medical devices

// Sell into Therapeutic and rehabilitation devices

AOS finds the biggest accounts in this submarket with a reason to talk now, maps their buying centre and prepares the outreach for your approval.